Answer
Raltegravir has an apparent terminal half-life of approximately 9 hours, with a shorter α-phase half-life of approximately 1 hour accounting for much of the AUC.
Sources for this answer
- Isentress 400 mg Film-coated TabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 37Document updated
Sources checked